Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) is a German-based multinational healthcare company that has been the world's largest provider of dialysis products and services since its founding in 1996. The company was created through the merger of Fresenius AG's dialysis division with National Medical Care, establishing a vertically integrated kidney care enterprise. Headquartered in Bad Homburg, Germany, Fresenius Medical Care operates over 4,100 outpatient dialysis clinics across approximately 150 countries and serves as both a direct care provider and a manufacturer of dialysis equipment and pharmaceuticals. The company has undergone significant strategic transformation in recent years, implementing its FME25 program to optimize operations and improve margins while maintaining its position as the dominant player in the global dialysis market.
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
—
MomentumView details →
1D Return
—
YTD Return
—
RSI (14)
—
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
—
Market Cap
—
RSI (14)
—
MomentumView details →
1D Return
—
YTD Return
—
SummaryUpdated Jun 1, 2026
Latest newsMore news →
Fresenius Medical Care AG bought back 1,175,030 shares between August 31 and September 4, 2026, as part of the first tranche of its share buyback program, bringing the total acquired to 7,764,435 shares.7d agoFresenius Medical Care AG appointed Cassie McLean as Management Board member and CEO of its Care Delivery segment, effective 1 August 2026, succeeding Craig Cordola.42d ago